Novo Nordisk A/S

Novo Terapeutisk Laboratorium A/S
Novo Alle 1
2880, Bagsværd , Hovedstaden Denmark
+45-44448888
Company Type: Limited Liability Company Subsidiary

D&B Business Directory

Novo Nordisk is one of the world's leading producers of diabetes therapies including human insulin, insulin analogues, and injection devices. It makes modern insulin analogues Levemir and NovoLog (which mimic natural insulin regulation more closely than human insulin), Victoza for type 2 diabetes, and Saxenda, which treats obesity. The firm also has products in the areas of hemostasis management (blood clotting), human growth hormone, and estrogen replacement therapy. The company has affiliates in some 80 countries and markets products in about 170 countries. The not-for-profit Novo Nordisk Foundation, through its Novo A/S subsidiary, controls the voting power in Novo Nordisk.

Try D&B Hoovers Free
Limited Liability Company Subsidiary
Doing Business As
Novo Terapeutisk Laboratorium A/S
Address
Novo Alle 1
2880, Bagsværd ​, HovedstadenDenmark
See other locations
Phone
+45-44448888
Company Description

Novo Nordisk is one of the world's leading producers of diabetes therapies including human insulin, insulin analogues, and injection devices. It makes modern insulin analogues Levemir and NovoLog (which mimic natural insulin regulation more closely than human insulin), Victoza for type 2 diabetes, and Saxenda, which treats obesity. The firm also has products in the areas of hemostasis management (blood clotting), human growth hormone, and estrogen replacement therapy. The company has affiliates in some 80 countries and markets products in about 170 countries. The not-for-profit Novo Nordisk Foundation, through its Novo A/S subsidiary, controls the voting power in Novo Nordisk.

Key Principal
Lars Fruergaard Jørgensen See more contacts
Industry
Pharmaceutical and Medicine Manufacturing Basic Chemical Manufacturing Medical Equipment and Supplies Manufacturing Pharmaceutical preparations Industrial organic chemicals, nec Medicinals and botanicals Surgical and medical instruments See all industries
D&B Hoovers Logo

For dynamic search and list-building capabilities, real-time trigger alerts, comprehensive company profiles, and valuable research and technology reports try D&B Hoovers for free!

Financial Statements

Financial data as of December 31, 2020 (12 month period) in USD

Annual Revenue 2020
$20.17 billion USD
1 USD = 6.2953 DKK

Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.

Competitor Profiles

See detailed profiles for insights and prospects on this company's top competitors.

Company Snapshot

Essential information for a successful call

  • EMPLOYEES (This Site) 1,000
  • ASSETS (MIL USD) 23,021
  • REVENUE (MIL USD) 20,165.12
  • TICKER SYMBOL NOVO B
  • Year Started 1931
  • Incorporated 2006
  • FISCAL YEAR END DEC
  • SALES GROWTH % 4.04%
  • NET INCOME GROWTH 8.18%

Similar Companies Nearby

Novo Nordisk A/S
Pharmaceutical Preparation Manufacturing
Krogshøjvej 51, Bagsværd, Hovedstaden
View Profile
Novo Nordisk A/S
Pharmaceutical Preparation Manufacturing
Krogshøjvej 49, Bagsværd, Hovedstaden
View Profile
Novo Nordisk A/S
Pharmaceutical Preparation Manufacturing
Krogshøjvej 46, Bagsværd, Hovedstaden
View Profile
Nn2
Pharmaceutical Preparation Manufacturing
Krogshøjvej 44, Bagsværd, Hovedstaden
View Profile

Get in Touch with 19 Principals*

A D&B Hoovers Subscription is your foot in the door to Novo Nordisk A/S contact information.
  • Lars Fruergaard Jørgensen
    Managing Director
  • Stig Strøbæk
    Staff representative on the board
  • Martin Holst Lange
    Director
  • Karsten Munk Knudsen
    Director

Want more contacts like these available directly in your inbox? Install D&B Email IQ to access your next prospects!

Free Install

Related Products

Grow Business FasterLearn More
D&B Finance Analytics Credit IntelligenceIntelligent Risk ManagementLearn More
Free Microsoft Outlook plugin to drive efficiency with on-demand sales intelligenceFree Install

Get full access to D&B Hoovers

With a Hoovers subscription you can get a comprehensive view of Novo Nordisk A/S

Novo Nordisk A/S*

19
Principals
See who the company's key decision makers are
434
Corporate Relations
Get the big picture on a company's affiliates and who they do business with.
9
Close Industry Peers
See similar companies for insight and prospecting.
*Contacts and Principals counts are estimates and may differ from the actual number of contacts available in D&B Hoovers.